New Delhi: The Indian Society for Scientific Analysis (ISCR) introduced the appointment of Dr. Seema Pai as its President for the time period 2025-2028. Dr. Pai succeeds Dr. Sanish Davis, who served as President from 2021 to 2025.
Dr. Seema Pai, with over 20 years of expertise in scientific analysis, presently leads Pfizer’s World Website and Research Operations for India, South Africa, and Sub-Saharan Africa. Recognized for her experience in scientific trial administration and regulatory affairs, she is going to concentrate on advancing ISCR’s mission to additional scientific analysis in India as its new President.
In her assertion, Dr. Pai stated, “It’s an honor to steer ISCR at such a pivotal second, particularly as the society celebrates its twentieth anniversary. As ISCR strikes ahead, our focus will stay on sustaining the very best requirements of high quality, pace, and ethics, whereas driving additional innovation in scientific trials and fostering larger collaboration throughout trade stakeholders.”
Reflecting on his tenure, outgoing President Dr. Sanish Davis expressed his gratitude for the chance to steer ISCR throughout a time of serious transformation in India’s scientific analysis ecosystem. “Throughout my tenure, ISCR has performed a pivotal function in advancing regulatory frameworks and fostering collaboration between trade and academia,” stated Dr. Davis. “I’m assured that underneath Dr. Pai’s management, ISCR will proceed to champion moral and progressive scientific analysis in India.
Source link
#ISCR #appoints #Seema #Pai #President #HealthWorld
